If you need more lookups,
subscriptions start at $34 USD/month.
James Schwindeman Location
Hilton Head Island, SC, US
James Schwindeman Work
Director of Business Development @ (December 2023 - Present)
Director Of Business Development - CDMO @ (August 2021 - December 2023)
Director of Business Development - CDMO @ (September 2019 - August 2021)
Executive Vice President, Sales and Business Development @ Rohner (February 2013 - August 2019)
Director, New Business Development @ Euticals (formerly Archimica) (April 2009 - January 2013)
Director of Business Development @ (March 2007 - March 2009)
Chief Operating Officer @ Tyger Scientific Inc. (January 2005 - January 2007)
Executive Account Manager @ (January 2004 - January 2005)
James Schwindeman Education
The Ohio State University
Ph.D. (Organic Chemistry)
1977-1981
Miami University
B.S. (Chemistry, ACS Certified Program)
1973-1977
James Schwindeman Skills
R&D
GMP
Business Development
Leadership
Sales
Analytical Chemistry
New Business Development
Technology Transfer
Drug Discovery
Chromatography
Organic Chemistry
CRM
Pharmaceutical Industry
Biotechnology
Lifesciences
Sales Operations
Chemistry
Management
HPLC
Polymers
Manufacturing
Catalysis
Chemical
Entrepreneurship
Medical Devices
Patents
Market Development
Validation
Regulatory Affairs
Organic Synthesis
Drug Development
Specialty Pharma
NMR
Medicinal Chemistry
Product Development
Formulation
Enterprise Software
Life Sciences
James Schwindeman Summary
James Schwindeman, based in Hilton Head Island, SC, US, is currently a Director of Business Development at LAXAI Life Sciences. James Schwindeman brings experience from previous roles at KD Pharma Group, Olon SpA, Rohner and Euticals (formerly Archimica). James Schwindeman holds a 1977 - 1981 Ph.D. in Organic Chemistry @ The Ohio State University. With a robust skill set that includes R&D, GMP, Business Development, Leadership, Sales and more. James Schwindeman has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different James Schwindeman?
Find contact details for 700 million professionals.